EN DE
Watch Source Natural Foods and Herbal Supplements Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Source Natural Foods and Herbal Supplements Limited (531398) fair value: what the stock is really worth

As of Nov 17, 2026: fair value (intrinsic value) of Source Natural Foods and Herbal Supplements Limited stock ₹100, price ₹112, that is 10.5% below the price, quality 52 out of 100. Rating: overvalued. Calculated from audited financials with 15 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Other IN

SN Thin data Nov 16, 2026

Source Natural Foods and Herbal Supplements Limited

531398 · BSE

Expensive (fair value 11% below the price) and falling price, but solid company: meets 1 of 3 rules.

Get notified free when this changes
Low debt 
Quality 52/100 
Expensive Growth (revenue 5y +23.1 %/yr in INR) 
Thin margins · 4.8% net margin (FY2026) 
Mixed vs. peers (5/10) 
Changed on Oct 28: ₹158.60 → ₹100.27 
Fair value ₹100.27 · Overvalued 
Falling price (downtrend) 
Negative free cash flow 
Narrow moat 42/100 · thin data
Thin data 
Watch Source Natural Foods and Herbal Supplements Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹264.50 ₹80.91 Fair Value ₹100.27 May 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

60‑month range ₹80.91 – ₹264.50 · fair‑value band ₹67.33 – ₹114.93 · the ₹112.05 price screens above the ₹100.27 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.

Follow Source Natural Foods and Herbal Supplements in your weekly email

Every Wednesday you see whether Source Natural Foods and Herbal Supplements is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Source Natural Foods and Herbal Supplements Limited manufactures and sells Ayurvedic medicines and herbal supplements products in India. The company was formerly known as Inwinex Pharmaceuticals Limited and changed its name to Source Natural Foods and Herbal Supplements Limited in June 2012.

Show moreShow less

Source Natural Foods and Herbal Supplements Limited was incorporated in 1995 and is based in Bengaluru, India. Source Natural Foods and Herbal Supplements Limited is a subsidiary of Sumeru Ayurveda Private Limited.

Stock analysis

Source Natural Foods and Herbal Supplements Limited (531398) currently trades at ₹112.05, while our model-based Fair Value estimate is ₹100.27, 11% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of ₹212.30 per share, and 5 of the 15 models we run sit above the ₹112.05 price.

Bear case: the Asset-Based group reads lowest at ₹25.62, and 10 of the 15 models stay below the price. Data coverage for this calculation is low.

Scenario range: ₹67.33 (bear) to ₹114.93 (bull), the price of ₹112.05 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 52/100 (solid quality), in the Other sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Source Natural Foods and Herbal Supplements Limited reported revenue of ₹704M in FY2026 versus ₹215M in FY2022, a compound +34.5%/yr. Reported net income was ₹34.0M in FY2026, compounding +8.7%/yr from FY2022.

Key figures

Market cap ₹721M (≈ $7.7M) Micro · P/E ratio 26.6 · P/S ratio 1.28 · EPS (TTM) ₹2.55 · Net margin 4.8% · Return on assets (EBIT) 13.9% (5-year average) · Free cash flow −₹30.9M · Net debt ₹55.8M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The share trades about 22% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Other peers we cover trades at −1% fair-value upside, at −11%, 531398 screens richer than that median.

Fair Value models

Bear ₹67.33 Fair Value ₹100.27 Bull ₹114.93
Price ₹112.05 · Downside -10.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (₹1.62 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV ₹59.10 ₹65.86 ₹71.36 74
Owner Earnings ₹36.04 ₹67.80 ₹123.52 73
ROIC Compounder ₹71.83 ₹100.27 ₹114.93 72
All 15 models by family
DCF Models
Owner Earnings ₹36.04 ₹67.80 ₹123.52 73
Earnings-Based
Graham-Dodd ₹35.91 ₹250.44 ₹351.46 63
Lynch FV ₹119.18 ₹170.26 ₹221.34 61
PEG = 1.0 ₹119.18 ₹170.26 ₹221.34 57
EPV ₹59.10 ₹65.86 ₹71.36 74
Multiples
P/E Multiple ₹67.33 ₹89.78 ₹112.22 63
P/S Multiple ₹67.33 ₹89.78 ₹112.22 58
P/B Multiple ₹87.40 ₹116.53 ₹145.66 55
EV/EBIT ₹81.28 ₹111.26 ₹141.24 66
EV/EBITDA ₹59.96 ₹82.83 ₹105.71 67
EV/Revenue ₹69.29 ₹102.70 ₹136.10 53
Asset-Based
NCAV (Graham) ₹16.91 ₹25.62 ₹32.03 54
Economic Profit
Residual Income ₹34.49 ₹38.93 ₹50.22 71
ROIC Compounder ₹71.83 ₹100.27 ₹114.93 72
Growth Earnings
Growth-Adj P/E ₹148.61 ₹212.30 ₹275.99 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 52/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 61
How much profit the company makes from its sales and capital
Quality Growth 53
Are margins and returns getting better?
Cashflow 3
Do the profits arrive as real cash?
Financial strength 72
Debt, balance sheet and risk of trouble
Investment 45
Does it invest with discipline instead of growing at any price?
Low Volatility 30
How calm the share price moves, does not count
Price momentum 27
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 16
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+56.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+52.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+23.1%
Start year 2021 (pandemic). Over 10 years: +20.5% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+25.7%
What shareholders gained per year (last 5 years), in INR (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+0.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+0.2%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.6.9% vs 9.2%, steady
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 8%
2026 sits 60% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2021 (pandemic)

531398 screens overvalued: fair value 11% below the price. Compare with 542772 →

Compare Source Natural Foods and Herbal Supplements Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Other · 97 stocks

Beats the industry median on 3/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 52 · Below median
Fair Value upside −10.5% · Above median
Profitability
Return on assets 8.3% · Top 25%
Net margin (12 months) 4.8% · Below median
Operating margin (12 months) 7.8% · Above median
Growth and dividend
Dividend yield (12 months) 0.0% · Bottom 25%

Valuation Multiplesvs Other median · lower = cheaper

P/E (12 months) 26.6× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)19 · sector 17
FUTURE (revenue growth)0 · sector 0
PAST (return on equity)0 · sector 25
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)0 · sector 27

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Other stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
532209 532209 ₹139.65 ₹308.03 +121% vs 531398
Balmer Lawrie Investments Limited BLIL ₹65.73 ₹101.84 +55% vs 531398
532468 532468 ₹2,239 ₹2,863 +28% vs 531398
542772 542772 ₹1,207 ₹1,294 +7% vs 531398
Indiabulls Real Estate Limited 532832 ₹50.78 ₹50.24 −1% vs 531398
590005 590005 ₹1,359 ₹1,253 −8% vs 531398
513023 513023 ₹545.90 ₹489.78 −10% vs 531398
Chambal Fertilisers and Chemicals Limited 500085 ₹371.15 ₹311.82 −16% vs 531398
542851 542851 ₹9.79 ₹6.49 −34% vs 531398
National Peroxide Limited 500298 ₹504.80 ₹63.57 −87% vs 531398

Explore undervalued stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Source Natural Foods and Herbal Supplements Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Source Natural Foods and Herbal Supplements Limited Fair Value". https://www.fairvalue-calculator.com/stock/531398

Frequently asked questions

Is Source Natural Foods and Herbal Supplements Limited (531398) overvalued or undervalued?
As of Nov 16, 2026, our model estimates a fair value of ₹100.27 versus a price of ₹112.05, about 11% lower (overvalued).
What is the fair value of 531398?
Our model-based fair value for Source Natural Foods and Herbal Supplements Limited is ₹100.27 (as of Nov 16, 2026), built from audited fundamentals. The current price: ₹112.05.
What is the quality score of 531398?
Source Natural Foods and Herbal Supplements Limited has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Source Natural Foods and Herbal Supplements Limited (531398)?
Our model-based price target is the fair value of ₹100.27 (as of Nov 16, 2026) from 15 valuation models. Cautious scenario ₹67.33, optimistic scenario ₹114.93. It is a calculation from audited fundamentals, not an analyst target.
What is the Source Natural Foods and Herbal Supplements Limited stock forecast for 2026?
Our models put fair value at ₹100.27, about 11% lower versus a price of ₹112.05 (overvalued). Cautious scenario ₹67.33, optimistic scenario ₹114.93. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Source Natural Foods and Herbal Supplements Limited (531398)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Source Natural Foods and Herbal Supplements Limited it is ₹100.27 per share (as of Nov 16, 2026), against a price of ₹112.05. It is the blended result of 15 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Source Natural Foods and Herbal Supplements Limited stock overvalued or undervalued in 2026?
As of Nov 16, 2026, 531398 trades above its calculated fair value: price ₹112.05, fair value ₹100.27, a gap of about −11% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 531398?
No. The price is what the market pays today (₹112.05); the fair value is what the company's own numbers justify (₹100.27). For Source Natural Foods and Herbal Supplements Limited the two are ₹11.78 per share apart. That gap is exactly why we show both numbers side by side.
How much is Source Natural Foods and Herbal Supplements Limited worth?
The market values Source Natural Foods and Herbal Supplements Limited at about ₹721M (market capitalisation, as of Nov 16, 2026). Per share that is ₹112.05; our models calculate a fair value of ₹100.27 per share.
What do the bullish and bearish scenarios say about 531398?
Our models span a range for Source Natural Foods and Herbal Supplements Limited: cautious scenario ₹67.33, base ₹100.27, optimistic ₹114.93 per share (as of Nov 16, 2026, price ₹112.05). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 531398?
Source Natural Foods and Herbal Supplements Limited trades at a price-to-earnings ratio of 26.6 (as of Nov 16, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹100.27 is built from several models across several years.
How far is 531398 from its 52-week high?
Source Natural Foods and Herbal Supplements Limited trades at ₹112.05, about 22% below its 52-week high of ₹143.90 and 9% above the low of ₹102.40 (as of Nov 17, 2026). Distance from the high says nothing about value: that is what the fair value of ₹100.27 is for.
Which stocks are comparable to Source Natural Foods and Herbal Supplements Limited?
From the same area (Other) we also value 542772, Chambal Fertilisers and Chemicals Limited, 532468, Indiabulls Real Estate Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Source Natural Foods and Herbal Supplements Limited stock attractive at the current price?
The data as of Nov 16, 2026: price ₹112.05, calculated fair value ₹100.27 (−11%), Quality Score 52/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 531398 calculated?
We run Source Natural Foods and Herbal Supplements Limited through 15 models from 6 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹100.27 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Source Natural Foods and Herbal Supplements Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Source Natural Foods and Herbal Supplements Limited (531398)?
The closing price on Nov 17, 2026 was ₹112.05. Our model-based fair value is ₹100.27, about 11% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Source Natural Foods and Herbal Supplements Limited right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the upper half of our model range, so the margin of safety is thin. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of Source Natural Foods and Herbal Supplements Limited

How large is the market capitalisation of Source Natural Foods and Herbal Supplements Limited (531398)?
The market capitalisation of Source Natural Foods and Herbal Supplements Limited is ₹721M (≈ $7.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Source Natural Foods and Herbal Supplements Limited (531398)?
The price-to-sales ratio of Source Natural Foods and Herbal Supplements Limited is 1.28 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Source Natural Foods and Herbal Supplements Limited (531398)?
Earnings per share at Source Natural Foods and Herbal Supplements Limited are ₹2.55 (price ÷ EPS = P/E 26.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Source Natural Foods and Herbal Supplements Limited (531398)?
The net margin of Source Natural Foods and Herbal Supplements Limited is 4.8% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Source Natural Foods and Herbal Supplements Limited (531398)?
On an EBIT basis the return on assets of Source Natural Foods and Herbal Supplements Limited is 13.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does Source Natural Foods and Herbal Supplements Limited (531398) generate?
The free cash flow of Source Natural Foods and Herbal Supplements Limited is −₹30.9M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Source Natural Foods and Herbal Supplements Limited (531398) carry?
The net debt of Source Natural Foods and Herbal Supplements Limited is ₹55.8M (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Source Natural Foods and Herbal Supplements Limited in the live analysis

One click puts Source Natural Foods and Herbal Supplements Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.